论文部分内容阅读
目的观察倍他乐克联合胺碘酮和镁剂治疗急性心肌梗死后室性心律失常的临床疗效。方法来我科行急诊抢救治疗的40例急性心肌梗死后室性心律失常患者(观察组),在常规治疗的基础上应用倍他乐克、胺碘酮和门冬氨酸钾镁;同时回顾性分析我科既往行急诊治疗的40例急性心肌梗死后室性心律失常患者的资料(对照组):在常规治疗的基础上只加用倍他乐克,比较两组的临床疗效。结果观察组的总有效率为92.5%,明显优于对照组(75.0%),差异有统计学意义(P<0.05);观察组室颤发生率和病死率分别为2.5%、0%,明显低于对照组,差异有统计学意义(P<0.05,P<0.05)。结论倍他乐克联合胺碘酮和镁剂治疗急性心肌梗死后室性心律失常疗效确切,能显著改善预后,值得临床上广泛应用。
Objective To observe the clinical efficacy of metoprolol combined with amiodarone and magnesium in the treatment of ventricular arrhythmias after acute myocardial infarction. Methods A total of 40 patients with ventricular arrhythmia after acute myocardial infarction (emergency group) undergoing emergency treatment in our department were treated with metoprolol, amiodarone and potassium magnesium aspartate on the basis of routine treatment. At the same time, To analyze the data of 40 patients with ventricular arrhythmia after acute myocardial infarction who had undergone emergency treatment in our department (control group): We only used metoprolol on the basis of routine treatment, and compared the clinical curative effect of the two groups. Results The total effective rate in the observation group was 92.5%, which was significantly better than that in the control group (75.0%), the difference was statistically significant (P <0.05). The incidence and mortality of ventricular fibrillation in the observation group were 2.5% and 0%, respectively Lower than the control group, the difference was statistically significant (P <0.05, P <0.05). Conclusion Betaloc combined with amiodarone and magnesium for the treatment of ventricular arrhythmia after acute myocardial infarction exact effect, can significantly improve the prognosis, it is widely used in clinical.